1Koletzko, B, Lien, E, Agostoni, C, et al. (2008) The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med 36, 5–14.
2Helland, IB, Saugstad, OD, Saarem, K, et al. (2006) Supplementation of n-3 fatty acids during pregnancy and lactation reduces maternal plasma lipid levels and provides DHA to the infants. J Matern Fetal Neonatal Med 19, 397–406.
3Dunstan, JA, Mori, TA, Barden, A, et al. (2004) Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. Eur J Clin Nutr 58, 429–437.
4Bergmann, RL, Haschke-Becher, E, Klassen-Wigger, P, et al. (2008) Supplementation with 200 mg/day docosahexaenoic acid from mid-pregnancy through lactation improves the docosahexaenoic acid status of mothers with a habitually low fish intake and of their infants. Ann Nutr Metab 52, 157–166.
5Innis, SM & Friesen, RW (2008) Essential n-3 fatty acids in pregnant women and early visual acuity maturation in term infants. Am J Clin Nutr 87, 548–557.
6Smuts, CM, Borod, E, Peeples, JM, et al. (2003) High-DHA eggs: feasibility as a means to enhance circulating DHA in mother and infant. Lipids 38, 407–414.
7Sanjurjo, P, Ruiz-Sanz, JI, Jimeno, P, et al. (2004) Supplementation with docosahexaenoic acid in the last trimester of pregnancy: maternal–fetal biochemical findings. J Perinat Med 32, 132–136.
8Montgomery, C, Speake, BK, Cameron, A, et al. (2003) Maternal docosahexaenoic acid supplementation and fetal accretion. Br J Nutr 90, 135–145.
9Otto, SJ, van Houwelingen, AC & Hornstra, G (2000) The effect of supplementation with docosahexaenoic and arachidonic acid derived from single cell oils on plasma and erythrocyte fatty acids of pregnant women in the second trimester. Prostaglandins Leukot Essent Fatty Acids 63, 323–328.
10Baylin, A & Campos, H (2006) The use of fatty acid biomarkers to reflect dietary intake. Curr Opin Lipidol 17, 22–27.
11Sun, Q, Ma, J, Campos, H, et al. (2007) Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr 86, 74–81.
12Umhau, JC, Dauphinais, KM, Patel, SH, et al. (2006) The relationship between folate and docosahexaenoic acid in men. Eur J Clin Nutr 60, 352–357.
13Sugiyama, K, Kumazawa, A, Zhou, H, et al. (1998) Dietary methionine level affects linoleic acid metabolism through phosphatidylethanolamine N-methylation in rats. Lipids 33, 235–242.
14Pita, ML & Delgado, MJ (2000) Folate administration increases n-3 polyunsaturated fatty acids in rat plasma and tissue lipids. Thromb Haemost 84, 420–423.
15Krauss-Etschmann, S, Shadid, R, Campoy, C, et al. (2007) Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial. Am J Clin Nutr 85, 1392–1400.
16Kolarovic, L & Fournier, NC (1986) A comparison of extraction methods for the isolation of phospholipids from biological sources. Anal Biochem 156, 244–250.
17Agren, JJ, Julkunen, A & Penttila, I (1992) Rapid separation of serum lipids for fatty acid analysis by a single aminopropyl column. J Lipid Res 33, 1871–1876.
18Lepage, G & Roy, CC (1986) Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27, 114–120.
19Helland, IB, Saugstad, OD, Smith, L, et al. (2001) Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics 108, E82.
20Barden, AE, Dunstan, JA, Beilin, LJ, et al. (2006) n-3 Fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clin Sci (Lond) 111, 289–294.
21Matorras, R, Perteagudo, L, Sanjurjo, P, et al. (1999) Intake of long chain w3 polyunsaturated fatty acids during pregnancy and the influence of levels in the mother on newborn levels. Eur J Obstet Gynecol Reprod Biol 83, 179–184.
22Vlaardingerbroek, H & Hornstra, G (2004) Essential fatty acids in erythrocyte phospholipids during pregnancy and at delivery in mothers and their neonates: comparison with plasma phospholipids. Prostaglandins Leukot Essent Fatty Acids 71, 363–374.
23Franke, C, Verwied-Jorky, S, Campoy, C, et al. (2008) Dietary intake of natural sources of docosahexaenoic acid and folate in pregnant women of three European cohorts. Ann Nutr Metab 53, 167–174.
24Fekete, K, Marosvolgyi, T, Jakobik, V, et al. (2009) Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review. Am J Clin Nutr 89, 2070S–2084S.
25Katan, MB, Deslypere, JP, van Birgelen, AP, et al. (1997) Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 38, 2012–2022.
26Cao, J, Schwichtenberg, KA, Hanson, NQ, et al. (2006) Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 52, 2265–2272.
27Arterburn, LM, Hall, EB & Oken, H (2006) Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 83, Suppl. 6, 1467S–1476S.
28Geppert, J, Kraft, V, Demmelmair, H, et al. (2005) Docosahexaenoic acid supplementation in vegetarians effectively increases omega-3 index: a randomized trial. Lipids 40, 807–814.
29Courville, AB, Keplinger, MR, Judge, MP, et al. (2009) Plasma or red blood cell phospholipids can be used to assess docosahexaenoic acid status in women during pregnancy. Nutr Res 29, 151–155.
30Vaysse, J, Dureuil, M, Pilardeau, P, et al. (1986) Plasma and erythrocyte lipid composition in normal pregnancy. Biol Res Pregnancy Perinatol 7, 89–92.
31Ruyle, M, Connor, WE, Anderson, GJ, et al. (1990) Placental transfer of essential fatty acids in humans: venous-arterial difference for docosahexaenoic acid in fetal umbilical erythrocytes. Proc Natl Acad Sci U S A 87, 7902–7906.
32Herrera, E (2002) Implications of dietary fatty acids during pregnancy on placental, fetal and postnatal development – a review. Placenta 23, S9–19.
33Legras, B, Durou, MR, Ruelland, A, et al. (1995) Serum lipid, apolipoprotein and lipoparticle levels in the human fetus. Prenat Diagn 15, 225–228.
34Nagasaka, H, Chiba, H, Kikuta, H, et al. (2002) Unique character and metabolism of high density lipoprotein (HDL) in fetus. Atherosclerosis 161, 215–223.